Immunisation and countermeasures division, National Infection Service, Public Health England, London, United Kingdom.
Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV service, National Infection Service, Public Health England, London, United Kingdom.
Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.8.1800055.
Opportunistic human papillomavirus (HPV) vaccination for men who have sex with men (MSM) was piloted in sexual health clinics (SHC) in England between 2016 and 2018.
to evaluate the pilot's first year (April 2016-March 2017) in terms of feasibility, acceptability, uptake, impact and equity and interpret the outcome in the context of wide HPV vaccination policy.
Attendance and uptake data from routine SHC surveillance datasets and a cross-sectional survey administered to individuals receiving the vaccine were analysed.
Among 18,875 eligible MSM, 8,580 (45.5%) were recorded as having received one HPV vaccine dose, decreasing slightly with increasing age, and uptake was higher in rural than urban areas. Survey results suggested that of those receiving the first dose of HPV vaccine, 8% were new attendees and that among those, less than 11% attended just to receive the vaccine. Of those having their first HPV vaccination, 95% indicated they would like to receive the next vaccine doses at the same clinic and 85% of patients reported accessing other services when visiting SHC for the first dose of vaccine.
An opportunistic HPV vaccination programme for MSM can be delivered in an acceptable and, as far as can be evaluated, equitable manner, without major disruption to SHC and HIV clinics.
2016 年至 2018 年期间，英国性健康诊所（SHC）对男男性行为者（MSM）进行了人乳头瘤病毒（HPV）疫苗接种的试点。
评估该试点项目的第一年（2016 年 4 月至 2017 年 3 月）的可行性、可接受性、接种率、影响和公平性，并结合广泛的 HPV 疫苗接种政策来解释结果。
分析来自常规 SHC 监测数据集的就诊和接种数据，以及对接受疫苗接种的个体进行的横断面调查。
在 18875 名符合条件的 MSM 中，有 8580 名（45.5%）记录接种了一剂 HPV 疫苗，随着年龄的增加略有下降，农村地区的接种率高于城市地区。调查结果表明，在接受 HPV 疫苗第一剂的人群中，有 8%是新就诊者，其中不到 11%的人仅仅是为了接种疫苗而就诊。在首次接种 HPV 疫苗的人群中，95%表示他们希望在同一诊所接种下一剂疫苗，85%的患者在首次接种疫苗时报告访问 SHC 时还使用了其他服务。
在不严重干扰 SHC 和 HIV 诊所的情况下，可以以可接受的、并且在可评估的公平方式，为 MSM 提供机会性 HPV 疫苗接种计划。
